Holen Sie sich die Stockscreener-App
1.63
0.94%
0.03
Handel nachbörslich:
1.61
-0.02
-1.23%
Schlusskurs vom Vortag:
$1.60
Offen:
$1.57
24-Stunden-Volumen:
6.71M
Relative Volume:
1.58
Marktkapitalisierung:
$476.46M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-63.08M
KGV:
-6.037
EPS:
-0.27
Netto-Cashflow:
$-72.53M
1W Leistung:
-8.24%
1M Leistung:
+50.93%
6M Leistung:
+140.58%
1J Leistung:
+70.02%
1-Tages-Spanne:
$1.51
$1.68
1-Wochen-Bereich:
$1.51
$1.88
52-Wochen-Spanne:
$0.515
$1.90
Ocugen Inc Stock (OCGN) Company Profile
Firmenname
Ocugen Inc
Sektor
Branche
Telefon
484-328-4701
Adresse
11 GREAT VALLEY PARKWAY, MALVERN, PA
Vergleichen Sie OCGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OCGN
Ocugen Inc
|
1.63 | 499.69M | 0 | -63.08M | -72.53M | -0.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Ocugen Inc Stock (OCGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-15 | Eingeleitet | Maxim Group | Buy |
| 2023-03-01 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2022-08-23 | Eingeleitet | Mizuho | Buy |
| 2022-06-15 | Fortgesetzt | ROTH Capital | Buy |
| 2022-06-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-07-26 | Eingeleitet | Noble Capital Markets | Outperform |
| 2021-06-11 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2021-05-07 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-02-09 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2021-02-04 | Hochstufung | H.C. Wainwright | Neutral → Buy |
Alle ansehen
Ocugen Inc Aktie (OCGN) Neueste Nachrichten
Can Ocugen Inc. (2H51) stock sustain double digit ROE2025 Volume Leaders & Fast Gain Swing Trade Alerts - newser.com
Ocugen Inc. stock prediction for this weekTrade Volume Report & Risk Controlled Stock Pick Alerts - newser.com
Will Ocugen Inc. stock maintain dividend yieldEarnings Recap Summary & Fast Entry High Yield Tips - newser.com
Combining price and volume data for Ocugen Inc.Long Setup & Free Growth Oriented Trading Recommendations - newser.com
How Ocugen Inc. stock reacts to job market dataWeekly Profit Report & Advanced Swing Trade Entry Alerts - newser.com
Signal strength of Ocugen Inc. stock in tech scannersWall Street Watch & Intraday High Probability Alerts - newser.com
Ocugen Stock Shock: What’s Next? - StocksToTrade
Best data tools to analyze Ocugen Inc. stockQuarterly Trade Review & Community Consensus Trade Alerts - newser.com
Tools to assess Ocugen Inc.’s risk profileMarket Volume Report & Safe Entry Point Alerts - newser.com
Ocugen (NASDAQ:OCGN) Shares Down 7.4%Should You Sell? - MarketBeat
Will Ocugen Inc. stock outperform international peers2025 Key Highlights & Reliable Price Breakout Signals - newser.com
Exit strategy if you’re trapped in Ocugen Inc.July 2025 Snapshot & AI Enhanced Market Trend Forecasts - newser.com
Weiss Ratings Reaffirms Sell (E+) Rating for Ocugen (NASDAQ:OCGN) - MarketBeat
What data driven models say about Ocugen Inc.’s futureWeekly Trading Summary & Community Verified Trade Signals - newser.com
How Ocugen Inc. (2H51) stock moves on employment data2025 Bull vs Bear & Daily Growth Stock Investment Tips - newser.com
A activityJuly 2025 Pullbacks & Verified Momentum Stock Watchlist - newser.com
Will earnings trigger a reversal in Ocugen Inc.Market Growth Review & Free Reliable Trade Execution Plans - newser.com
Ocugen Secures ATMP Classification for Gene Therapies Targeting Vision Loss - MSN
Ocugen, Inc. Hits New 52-Week High of $1.90, Marking Major Milestone - Markets Mojo
Ocugen to Highlight Gene Therapy Pipeline at Key Industry and Investor Conferences - MyChesCo
Published on: 2025-10-06 02:02:01 - newser.com
Automated trading signals detected on Ocugen Inc.Market Rally & Weekly Breakout Opportunity Watchlist - newser.com
Analyzing recovery setups for Ocugen Inc. investorsJuly 2025 WrapUp & Free Daily Entry Point Trade Alerts - newser.com
Real time pattern detection on Ocugen Inc. stockFed Meeting & Smart Money Movement Alerts - newser.com
Published on: 2025-10-05 03:08:53 - newser.com
What drives Ocugen Inc 2H51 stock priceBull Market Opportunities & Explosive Growth Opportunities - earlytimes.in
Is Ocugen Inc 2H51 a good long term investmentPrice Volatility Patterns & You’ll Regret Not Buying These Early - earlytimes.in
Ocugen (NASDAQ:OCGN) Hits New 52-Week HighHere's Why - MarketBeat
Published on: 2025-10-03 06:57:10 - newser.com
Regression analysis insights on Ocugen Inc. performanceTrade Volume Report & Low Risk High Reward Ideas - newser.com
How to recover losses in Ocugen Inc. stockGap Down & Entry and Exit Point Strategies - newser.com
Published on: 2025-10-03 02:54:41 - newser.com
Ocugen, Inc. to Present at NobleCon20 Emerging Growth Equity Conference - MSN
Ocugen to Present at Major Biotechnology Conferences Focused on Advancements in Gene Therapies for Blindness Diseases - Quiver Quantitative
Ocugen to Present at Industry and Investor Conferences in October 2025 - GlobeNewswire
Targeting 3 BLA Submissions: Ocugen Leadership to Present Gene Therapy Vision at Major Industry Events - Stock Titan
Traders Buy High Volume of Ocugen Call Options (NASDAQ:OCGN) - MarketBeat
Ocugen Inc Stock Analysis and ForecastInsider Selling Patterns & High Return Capital Gains - earlytimes.in
Ocugen Strikes $7.5 Million Licensing Deal With Kwangdong for Gene Therapy in Korea - MSN
Finanzdaten der Ocugen Inc-Aktie (OCGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):